Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 7 - Drugs for disorders of the blood or the extracellular fluid
Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065)
10/2000
10/03/2000US6127340 Espcecially thrombin, in which the p1-p2 natural amide linkage is replaced by another bond; inhibiting coagulation of blood in a container; treatment or prevention of thrombosis
10/03/2000US6127335 Cyclic adhesion inhibitors
10/03/2000US6127111 Stable preparation for diagnosis and therapy
10/03/2000US6126832 Composition for dialysis and shock treatment
10/03/2000CA2006953C Methods and compositions for treatment of pathological hydrophobic interactions in biological fluids.
10/03/2000CA2000342C Novel peptidase inhibitors
09/2000
09/28/2000WO2000056910A1 Retroviral vectors comprising functional and non-functional splice donor and splice acceptor sites
09/28/2000WO2000056891A2 Human transmembrane proteins
09/28/2000WO2000056889A2 Secreted and transmembrane polypeptides and nucleic acids encoding the same
09/28/2000WO2000056885A1 Protein for blocking platelet adhesion
09/28/2000WO2000056882A1 48 human secreted proteins
09/28/2000WO2000056881A1 48 human secreted proteins
09/28/2000WO2000056880A1 50 human secreted proteins
09/28/2000WO2000056772A1 Human antibodies that bind human il-12 and methods for producing
09/28/2000WO2000056767A1 46 human secreted proteins
09/28/2000WO2000056766A1 47 human secreted proteins
09/28/2000WO2000056765A1 48 human secreted proteins
09/28/2000WO2000056755A1 49 human secreted proteins
09/28/2000WO2000056754A1 48 human secreted proteins
09/28/2000WO2000056751A1 50 human secreted proteins
09/28/2000WO2000056738A1 Pyridine and pyrimidine derivatives and their use as inhibitors of cytokine mediated disease
09/28/2000WO2000056737A2 Calanolides for inhibiting btk
09/28/2000WO2000056710A1 3-(anilinomethylene) oxindoles as protein tyrosine kinase and protein serine/threonine kinase inhibitors
09/28/2000WO2000056704A1 Hydroxamic and carboxylic acid derivatives
09/28/2000WO2000056403A1 UPREGULATION OF TYPE III ENDOTHELIAL CELL NITRIC OXIDE SYNTHASE BY HMG-CoA REDUCTASE INHIBITORS
09/28/2000WO2000056367A1 Hemoglobin-antioxidant conjugates
09/28/2000WO2000056322A1 Treatment to lower platelet adhesiveness
09/28/2000WO2000056304A2 Anti-inflammatory uses of manzamines
09/28/2000WO2000056153A1 Oral low dose butyrate compositions
09/28/2000WO2000041545A3 Regulators of the pct or smoothened pathway, compositions and uses related thereto
09/28/2000WO2000035428A3 Tricyclic nitrogen heterocycles as pde iv inhibitors
09/28/2000WO2000033822A9 Active ingredient matrix in the form of a biologically resorbable porous non-woven made of collagen fibrils, method for the production and use thereof
09/28/2000WO2000022143A3 Protein kinase homologs
09/28/2000WO2000020447A3 Polynucleotides coding for secreted polypeptides, some having similarity to syncollin or claudin or cytokine, their therapeutic uses
09/28/2000WO2000018796A3 Secretory protein- zsig48
09/28/2000WO2000015793A3 Human gpcr proteins
09/28/2000WO2000013706A9 Methods for detecting, preventing, and treating renal disorders by modulating, regulating, and inhibiting connective tissue growth factor
09/28/2000DE19913731A1 Medizinische Zubereitung, enthaltend als Wirkstoff zumindest einen Anteil von Acetylsalicylsäure Medical preparation comprising as active ingredient at least a portion of acetylsalicylic acid
09/28/2000DE19912850A1 Lösung, insbesondere für Hämo- oder Peritonealdialyse, sowie Verfahren zu deren Herstellung Solution, in particular for hemodialysis or peritoneal dialysis, as well as processes for their preparation
09/28/2000CA2669512A1 Human antibodies that bind human il-12 and methods for producing
09/28/2000CA2368229A1 50 human secreted proteins
09/28/2000CA2368223A1 48 human secreted proteins
09/28/2000CA2368210A1 50 human secreted proteins
09/28/2000CA2368187A1 Upregulation of type iii endothelial cell nitric oxide synthase by hmg-coa reductase inhibitors
09/28/2000CA2367963A1 Hydroxamic and carboxylic acid derivatives
09/28/2000CA2367866A1 Pyridine and pyrimidine derivatives and their use as inhibitors of cytokine mediated disease
09/28/2000CA2367620A1 47 human secreted proteins
09/28/2000CA2367488A1 Retroviral vectors comprising functional and non-functional splice donor and splice acceptor sites
09/28/2000CA2367041A1 Treatment to lower platelet adhesiveness
09/28/2000CA2366691A1 48 human secreted proteins
09/28/2000CA2366650A1 Oral low dose butyrate compositions
09/28/2000CA2366132A1 48 human secreted proteins
09/28/2000CA2365247A1 49 human secreted proteins
09/28/2000CA2365244A1 Calanolides for inhibiting btk
09/28/2000CA2365243A1 Human transmembrane proteins
09/28/2000CA2365238A1 48 human secreted proteins
09/28/2000CA2365223A1 46 human secreted proteins
09/28/2000CA2361221A1 Novel protein which induces chondrocyte differentiation
09/27/2000EP1038959A1 Factor VIII without B-domain, comprising one or more insertions of a truncated intron I of factor IX
09/27/2000EP1038552A2 Solution, in particular a hemodialysis or peritoneal dialysis solution, and method for producing same
09/27/2000EP1038524A1 L-threonate ferrous, as well as pharmaceutical composition and use for improving and treating human anemia thereof
09/27/2000EP1037969A1 Fibrinogen-converting enzyme hybrids
09/27/2000EP1037923A1 Method for preparing by filtration a virally secure factor viii solution
09/27/2000EP1037921A1 Erythropoietin with high specific activity
09/27/2000EP1037906A1 Cyclopeptide derivatives with integrin inhibitor properties
09/27/2000EP1037659A1 Fibrinolytic inhibitor for sealant
09/27/2000EP1037655A2 Methods of treatment using novel ligands of the neuropeptide receptor hfgan72 and agonists or antagonists thereof
09/27/2000EP1037529A1 Composition useful for providing one-step surgical preparation and drape
09/27/2000EP0918792B1 Dipeptide benzamidine as a kininogenase inhibitor
09/27/2000EP0689592B1 Stable bactericidal/permeability-increasing protein products and pharmaceutical compositions containing the same
09/27/2000CN1268186A i (in vivo) use of recombinagenic oligonucleobases to correct genetic lesions in hepatocytes
09/27/2000CN1268067A Blood processing system and method which optically derive the volume of platelets contained in a plasma constituent
09/27/2000CN1268054A Combination therapy comprising amlodipine and a statin compound
09/27/2000CN1268052A Therapeutic combinations comprising amlodipin and atorvastatin
09/27/2000CN1056844C Dioxide pyrrolo-pyrrolo derivatives
09/26/2000US6124332 Metalloproteinase inhibitors
09/26/2000US6124329 Metalloproteinase inhibitors
09/26/2000US6124277 Antithrombotic agents
09/26/2000US6124273 Sustained release wound healing agents
09/26/2000US6124101 Diagnosis of thrombosis in a mammals; incubating a sample of fluid with an antibody that preferentially binds a cleaved activation peptide, counting antibody bound cleaved activation peptides, compare to control
09/21/2000WO2000055352A2 50 human secreted proteins
09/21/2000WO2000055343A2 Retrovirus producting cells utilizing a high multiplicity of transduction
09/21/2000WO2000055332A2 Human regulators of intracellular phosphorylation
09/21/2000WO2000055199A1 47 human secreted proteins
09/21/2000WO2000055196A1 Protamine fragment compositions and methods of use
09/21/2000WO2000055161A1 6-substituted biaryl purine derivatives as potent cyclin/cdk inhibitors and antiproliferative agents
09/21/2000WO2000055159A2 Substituted aza-oxindole derivatives
09/21/2000WO2000055156A1 Substituted aromatic amidine derivative and medicinal composition comprising the same
09/21/2000WO2000055155A2 Heterocyclic compounds as adenosine deaminase inhibitors
09/21/2000WO2000055152A1 Aromatic heterocyclic compounds as anti-inflammatory agents
09/21/2000WO2000055139A2 Heterocyclic urea and related compounds useful as anti-inflammatory agents
09/21/2000WO2000055120A1 Amide derivatives
09/21/2000WO2000055114A1 Substituted 2-aminobenzamide caspase inhibitors and the use thereof
09/21/2000WO2000040716A3 Soluble receptor br43x2 and methods of using them for therapy
09/21/2000WO2000040583A3 Imidazo[4,5-c]-pyridine-4-on-derivatives
09/21/2000WO2000032577A3 Substituted benzo[de]isoquinoline-1,3-diones
09/21/2000WO2000026227A9 Ldl related protein and uses thereof
09/21/2000CA2367354A1 6-substituted biaryl purine derivatives as potent cyclin/cdk inhibitors and antiproliferative agents
09/21/2000CA2367340A1 Substituted 2-aminobenzamide caspase inhibitors and the use thereof
09/21/2000CA2365655A1 Retrovirus producting cells utilizing a high multiplicity of transduction
1 ... 512 513 514 515 516 517 518 519 520 521 522 523 524 525 526 527 528 529 530 531 532 ... 671